Abstract
Neuroblastoma is one of the most common solid tumors in children with a poor prognosis at the IV stage. A common marker of neuroblastoma is a high expression of tyrosine hydroxylase. DNA vaccination is a concomitant method of treatment of oncological diseases that are characterized by a high probability of long-term remission and a risk of subsequent relapse. We performed the DNA vaccination of A/J mice using a tyrosine hydroxylase (TH) design as a tumor antigen. Polyethylenimine was used as a synthetic carrier for vaccine delivery. It was shown that the conjugation of the developed vaccine with polyethylenimine increases the vaccine immunogenicity, which is manifested both in slowing the tumor progression and in activating the cellular immunity, including the cytotoxic T-cell response and the gamma-interferon production.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the National Academy of Sciences of Belarus, Medical series
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
